A Trial Testing Amiodarone in Chagas Cardiomiopathy
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Purpose:
The ATTACH trial, as currently designed, will primarily test whether a treatment with
Amiodarone for at least 6 months has a trypanocidal effect among individuals with
mild-to-moderate Chronic Chagas Cardiomyopathy. A secondary goal will be to confirm, in this
population, a clinical benefit from this treatment (in terms of reducing mortality or cardiac
arrhythmic events), and to explore whether a potential trypanocidal effect is associated with
a clinical benefit.